Syngex's Nexa-IT
Rabeprazole 20 mg + Itopride 150 mgMARKETER: Syngex Pharma Pvt Ltd
NEXA IT is a combination of Rabeprazole 20 mg and Itopride 150 mg designed to provide effective relief in patients suffering from GERD, acid reflux, dyspepsia, bloating, post-meal fullness and upper GI discomfort associated with impaired gastric motility. Rabeprazole offers potent acid suppression, while Itopride improves gastric motility and gastric emptying for more comprehensive symptom relief. Rabeprazole + itopride combinations are commonly used for GERD / acid reflux and peptic-ulcer / acid-peptic symptoms, especially when reflux is accompanied by bloating, heaviness or dyspeptic complaints.
HOW NEXA IT TABLET WORKS
Rabeprazole 20 mg – Acid Suppression
Rabeprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion. It helps relieve:
- Heartburn
- Acid regurgitation
- Epigastric burning
- Acid-related irritation
Itopride 150 mg – Prokinetic Support
Itopride improves upper GI motility and gastric emptying. It helps:
- Improve gastric movement
- Reduce post-meal fullness
- Reduce bloating and heaviness
Relieve nausea and dyspeptic discomfort
Composition
- Rabeprazole Sodium IP equivalent to Rabeprazole 20 mg
- Itopride Hydrochloride IP 150 mg
Therapy Segment
Gastroenterology / Acid Peptic Disorders / PPI + Prokinetic Combination
Key Indications
NEXA IT may be prescribed for:
- Gastroesophageal Reflux Disease (GERD)
- Acid reflux with post-meal fullness
- Functional dyspepsia
- Bloating, heaviness and indigestion
- Heartburn and regurgitation
- Upper abdominal discomfort associated with delayed gastric emptying
- Nausea and fullness linked with gastric dysmotility
Combination Benefit
The PPI + prokinetic combination addresses both excess gastric acid and impaired gastric motility, making it useful when reflux is accompanied by bloating, heaviness or dyspeptic symptoms.